{
    "id": 1702,
    "fullName": "FLT3 Y599_D600insGLYVDFREYEY",
    "impact": "insertion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "FLT3 Y599_D600insGLYVDFREYEY results in the insertion of 11 amino acids in the cytoplasmic juxtamembrane region of the Flt3 protein between amino acids 599 and 600 (PMID: 11756186). Y599_D600insGLYVDFREYEY results in transformation in cell culture (PMID: 11756186) and therefore, is predicted to lead to a gain of Flt3 protein function.",
            "references": [
                {
                    "id": 705,
                    "pubMedId": 11756186,
                    "title": "FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/11756186"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2322,
        "geneSymbol": "FLT3",
        "terms": [
            "FLT3",
            "CD135",
            "FLK-2",
            "FLK2",
            "STK1"
        ]
    },
    "variant": "Y599_D600insGLYVDFREYEY",
    "createDate": "09/15/2014",
    "updateDate": "10/05/2018",
    "referenceTranscriptCoordinates": {
        "id": 144626,
        "transcript": "NM_004119",
        "gDna": "chr13:g.28034124_28034125insCTCATACTCCCTAAAGTCTACATAAAGACCATA",
        "cDna": "c.1798_1799insGTCTTTATGTAGACTTTAGGGAGTATGAGTATG",
        "protein": "p.Y599_D600insGLYVDFREYEY",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1041,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, tandutinib (CT53518) inhibited proliferation of cells expressing FLT3 Y599_D600insGLYVDFREYEY in culture (PMID: 12124172).",
            "molecularProfile": {
                "id": 1739,
                "profileName": "FLT3 Y599_D600insGLYVDFREYEY"
            },
            "therapy": {
                "id": 933,
                "therapyName": "Tandutinib",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 749,
                    "pubMedId": 12124172,
                    "title": "CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/12124172"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1739,
            "profileName": "FLT3 Y599_D600insGLYVDFREYEY",
            "profileTreatmentApproaches": [
                {
                    "id": 4007,
                    "name": "FLT3 Inhibitor",
                    "profileName": "FLT3 Y599_D600insGLYVDFREYEY"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 144626,
            "transcript": "NM_004119",
            "gDna": "chr13:g.28034124_28034125insCTCATACTCCCTAAAGTCTACATAAAGACCATA",
            "cDna": "c.1798_1799insGTCTTTATGTAGACTTTAGGGAGTATGAGTATG",
            "protein": "p.Y599_D600insGLYVDFREYEY",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}